Expanding the heart failure community.
Summary of "Expanding the heart failure community."
No Summary Available
Affiliation
President, American Association of Heart Failure Nurses, Mount Laurel, New Jersey.
Journal Details
This article was published in the following journal.
Name: Heart & lung : the journal of critical care
ISSN: 1527-3288
Pages: 321-2
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22741538
- DOI: http://dx.doi.org/10.1016/j.hrtlng.2012.04.011
Medical and Biotech [MESH] Definitions
Heart Failure
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
Cardiomegaly
Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
Heart Failure, Diastolic
Heart failure caused by abnormal myocardial relaxation during DIASTOLE leading to defective cardiac filling.
Heart Failure, Systolic
Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
PubMed Articles
Epidemiology of Anemia in Heart Failure.
Anemia is being increasingly recognized as an important comorbidity in patients with heart failure. Despite wide variations in defining anemia, approximately one-fifth to one-third of patients with he...
Systolic and diastolic heart failure are overlapping phenotypes within the heart failure spectrum.
This study sought to determine the potential pathophysiological link between anemia and disease severity, and adverse outcome in heart failure (HF).
Treatment options in end-stage heart failure: where to go from here?
Chronic heart failure is a major healthcare problem associated with high morbidity and mortality. Despite significant progress in treatment strategies, the prognosis of heart failure patients remains...
Are beta2-agonists responsible for increased mortality in heart failure?
Previous large-scale, retrospective studies have shown increased mortality in heart failure (HF) patients using β2-agonists (B2As). We further examined the relationship between B2A use and mortality...
Clinical Trials
Monitoring Community Trends in Heart Failure
To examine temporal trends from 1995 and 2000 in the incidence rates of heart failure, its therapeutic management, and changes over time in the hospital and long-term survival of patients...
Heart Failure in the Community
To monitor trends in congestive heart failure in Olmsted County, Minnesota.
A Study Of The Usage Of Statins In A Community Heart Failure Population
Inflammation and fibrosis may be important contributors to worsening heart failure. As well as lowering cholesterol, statins are also known to reduce inflammatory markers such as C-reactiv...
This study was designed to determine if patients, who have both high blood pressure and heart failure and are currently receiving drug treatment for heart failure, have an improvement in t...
Comprehensive Heart Failure Disease Management Community Program
The purpose of this study is to determine whether a nurse-led, comprehensive disease management program is effective in reducing recurrent hospital admissions and deaths in community dwell...
